Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Abstract
Context Hypopituitarism in adults is known to be associated with deleterious effects on body composition, lipid profile and quality of life (QoL). This was attributed to GH deficiency. The potential role of glucocorticoid overreplacement had never been investigated. Objective To investigate whether reduction in glucocorticoid replacement dose to more physiological one could ameliorate the "AO-GHD"-attributed symptomatology in patients with hypopituitarism. Design Eleven patients with panhypopituitarism taking 20-30 mg/day of hydrocortisone, but on no GH replacement were switched to 10-15 mg of hydrocortisone daily. Both basally and 6-12 months later, their body mass index, body composition by dual-energy X-ray absorptiometry, lipid profile, and the score of quality of life, QOL-AGHDA were measured. Results Within 6-12 months of lower hydrocortisone dose, subjects lost an average of 7.1 kg of total body fat and 4.1 kg of abdominal fat. No changes were seen in lean body mass, bone mineral content and HOMA-IR. Plasma total cholesterol and triglyceride concentrations decreased significantly ( Conclusions Our pilot study suggests that decreasing the glucocorticoid replacement dose to approximately 15 mg/day is beneficial in terms of patients' body composition, lipid profile and quality of life.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is no apparent dosedependent difference in integrated cortisol daily curves between patients on half-dose or no HC replacement (211), suggesting that current conventional full GC replacement doses might over-treat patients with partial ACTH deficiency.”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [211]
In the citing paper
“There is no apparent dosedependent difference in integrated cortisol daily curves between patients on half-dose or no HC replacement (211), suggesting that current conventional full GC replacement doses might over-treat patients with partial ACTH deficiency.”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [211]
Citations
Cites
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402 · cited 1×
“They include abnormal body composition with increased adiposity, thin skin, osteopenia, hyperlipidemia, insulin resistance and diminished quality of life [ 10 , 11].”
BackgroundDaily cortisol production rate in man determined by stable isotope dilution/mass spectrometry
ESTEBAN, N. V., LOUGHLIN, T., YERGEY, A. L., ZAWADZKI, J. K., BOOTH, J. D., WINTERER, J. C., & LORIAUX, D. L. (1991) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-72-1-39 · Cited by 481 · cited 1×
“that the actual cortisol secretion rates in healthy humans are substantially lower than what was previously thought [8].”
ResultLong-term follow-up of the West of Scotland Coronary Prevention Study
Ford, I., Murray, H., Packard, C. J., Shepherd, J., Macfarlane, P. W., & Cobbe, S. M. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa065994 · Cited by 416
Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321 · cited 1×
“The relatively modest excess in glucocorticoid replacement may have biological consequences: subjective health status in patients with hypoadrenalism is inversely proportionate to their glucocorticoid replacement dosage [20], and the ‘‘metabolic’’ abnormalities (BMI, waist circumference and lipids) in panhypopituitary…”
BackgroundWhich Patients Do Not Require a GH Stimulation Test for the Diagnosis of Adult GH Deficiency?
Hartman, M. L. (2002) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.87.2.477 · Cited by 319
Hahner, S., Loeffler, M., Fassnacht, M., Weismann, D., Koschker, A.-C., Quinkler, M., Decker, O., Arlt, W., & Allolio, B. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0685 · Cited by 282 · cited 1×
“[20], and the ‘‘metabolic’’ abnormalities (BMI, waist circumference and lipids) in panhypopituitary patients have”
BackgroundMcKenna, S. P., Doward, L. C., Alonso, J., Kohlmann, T., Niero, M., Prieto, L., & Wíren, L. (1999) · Quality of Life Research · doi:10.1023/a:1008987922774 · Cited by 263 · cited 1×
“A Spanish version of QoL-AGHDA questionnaire [9] was utilized to assess the subjects’ quality of life.”
MethodJohannsson, G. (1996) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.81.8.2865 · Cited by 258 · cited 1×
“Indeed, many studies asserting the existence of AO-GHD used similar glucocorticoid replacement dosages [5–7].”
BackgroundSesmilo, G., Biller, B. M. K., Llevadot, J., Hayden, D., Hanson, G., Rifai, N., & Klibanski, A. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-133-2-200007180-00010 · Cited by 257 · cited 1×
“Similarly, GH treatment either does not change insulin sensitivity [14]or actually worsens it [15].”
BackgroundThe Australian Multicenter Trial of Growth Hormone (GH) Treatment in GH-Deficient Adults1
Cuneo, R. C., Judd, S., Wallace, J. D., Perry-Keene, D., Burger, H., Lim-Tio, S., Strauss, B., Stockigt, J., Topliss, D., Alford, F., et al. (1998) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.83.1.4482 · Cited by 245 · cited 1×
“Similarly, GH treatment either does not change insulin sensitivity [14]or actually worsens it [15].Also, whereas the improvement in QoL was repeatedly asserted in many open label trials, no such finding was reported in large double-blind, placebo-controlled studies [13], even when only the patients with the most sever…”
Result
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Johannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329
“In an attempt to improve patient outcome, studies in which both the dose and the dosing strategies were adjusted have been performed (14–16).”
Glucocorticoids and the regulation of growth hormone secretion
Mazziotti, G., & Giustina, A. (2013) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2013.5 · Cited by 206
Adrenal insufficiency: review of clinical outcomes with current glucocorticoid replacement therapy
Johannsson, G., Falorni, A., Skrtic, S., Lennernäs, H., Quinkler, M., Monson, J. P., & Stewart, P. M. (2015) · Clinical Endocrinology · doi:10.1111/cen.12603 · Cited by 122
Psychosomatic aspects of Cushing’s syndrome
Sonino, N., Fallo, F., & Fava, G. A. (2009) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-009-9123-7 · Cited by 122
Metadata
- Authors
- Danilowicz, K., Bruno, O. D., Manavela, M., Gomez, R. M., & Barkan, A.
- Affiliations
- Hospital de Clínicas "José de San Martín" (AR)
- University of Michigan (US)
- Corresponding author
- Danilowicz, Karina
- Venue
- Pituitary
- Published
- 2008-05-06
- Volume
- 11
- Issue
- 3
- Pages
- 279-285
- ISSN
- 1386-341X (ISSN-L)
- 1573-7403
- OpenAlex
- W1888215607
- Semantic Scholar
- 13851fb47b77b0da5a3ce870cea9f02253ee71ab
- Cited by
- 72
- References
- 28
- Citations by year
- 2026: 1 · 2024: 3 · 2023: 1 · 2022: 4 · 2021: 4 · 2020: 5 · 2019: 1 · 2018: 6 · 2017: 1 · 2016: 9 · 2015: 2 · 2014: 11 · 2013: 3 · 2012: 4
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Pituitary (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pituitary Gland Disorders and Treatments
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Keywords
- hypopituitarism, panhypopituitarism, growth hormone deficiency, body composition, lipid profile, quality of life, insulin resistance, cholesterol, triglycerides
- MeSH terms
- Adult, Aged, Body Composition, Cushing Syndrome, Dose-Response Relationship, Drug, Female, Glucocorticoids, Humans, Hydrocortisone, Hypopituitarism, Lipids, Male, Middle Aged, Pilot Projects, Quality of Life, Surveys and Questionnaires, Absorptiometry, Photon, Body Mass Index, Treatment Outcome, Human Growth Hormone, Hormone Replacement Therapy, Lipid Metabolism
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. https://app.cochat.ai/papers/10.1007/s11102-008-0126-2
- The paper
- Danilowicz, K., Bruno, O. D., Manavela, M., Gomez, R. M., & Barkan, A. (2008). Correction of cortisol overreplacement ameliorates morbidities in patients with hypopituitarism: a pilot study. Pituitary. https://doi.org/10.1007/s11102-008-0126-2
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.